Sanofi (France) to Buy Animal Health Division of Dosch Pharma

Published: Dec 20, 2012

French drug-maker Sanofi has entered into an agreement to acquire the animal health division of Indian firm Dosch Pharmaceuticals for an undisclosed amount. Sanofi in a statement said that its animal health division Merial has entered into a binding agreement to acquire the animal health division of Dosch Pharmaceuticals, creating a market entry for Merial in the country's strategically important and growing animal health sector. The agreement is subject to regulatory approval and is expected to finalise sometime in the first half of 2013, it added. The company, however, did not disclose financial details. "The acquisition of Dosch's Animal Health Division will be a significant milestone for Merial and give us a strategic platform for our development in the Indian market," said. Merial Chief Executive Officer Jose Barella. Barella added that combination of Dosch's animal health brands and distribution strength, along with the robust new product pipelines from both Merial and Dosch, will strongly position Merial to become rapidly a major animal health player in India. Mumbai-headquartered Dosch Pharmaceuticals is a diversified pharmaceutical company, primarily operating through two divisions, animal health and exports. "The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals," the statement said. Products include an extensive range of animal health therapeutics and nutritional feed supplements. Within the animal health division, Dosch has a 279 member sales force, covering 18 Indian states. "The strong nationwide sales, marketing and distribution network of Dosch, along with established products and people will be an ideal platform for Merial to enter the fast developing animal health market of India," Dosch Chairman and Managing Director Sanjay Doshi said.

Back to news